Advertisement

Topics

Cytopia Limited Company Profile

02:20 EST 12th December 2018 | BioPortfolio

Cytopia aims to identify new candidate therapeutics (drug leads) for asthma and a range of inflammatory diseases. Many current drugs have significant side effects such as gastric upsets and ulcers and Cytopia's technology has the potential to discover more specific drugs without these side effects.

Cytopia has an exclusive, worldwide royalty-free license to commercially exploit technology developed by its Research Director, Dr Andrew Wilks, whilst at the Ludwig Institute for Cancer Research in Melbourne.



Licensed patents give Cytopia sole right to commercially exploit several genes and protein (known as JAK kinases) which play a crucial role in controlling the inflammatory process, for example in rheumatoid arthritis.



Cytopia is developing technology which allows large chemical collections to be tested for their ability to inhibit the activity of the patented proteins. Chemicals which are specifically active may be able to prevent certain inflammatory diseases.

Location

41, Victoria Parade
Fitzroy
Victoria
3065
Australia

Contact

Phone: (613) 9288 2973
Fax: 613 9288 2013
Email: cytopia@cytopia.com.au


News Articles [33 Associated News Articles listed on BioPortfolio]

Implicit Bioscience: Accelerating Value Creation in Biotech Firms

Fintan Walton talks to Dick Haiduck about his work with Implicit Bioscience, Cytopia and others, and his ‘partner to CEO’ service. Dick describes these two different companies - both based in Aust...

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Quotient Limited Announces Initial MosaiQ™ SDS Verification and Validation Data

JERSEY, Channel Islands, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported positive Verification and Validation...

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously annou...

Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an ...

Quotient Limited Announces Completion of Senior Secured Notes Offering

JERSEY, Channel Islands, July 02, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), has completed the offering of up to $120.0 million ...

Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference

JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop,...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [88 Associated Companies listed on BioPortfolio]

Cytopia Ltd.

Cytopia Ltd is an Australian biotechnology company focused on the discovery and development of new drugs to treat cancer and other diseases. Cytopia conducts its research and drug development through...

Cytopia

Cytopia's mission is to become a leading discoverer of targeted small molecule therapeutics for diseases such as cancer, cardiovascular and immune disease, delivering drug candidates at various stages...

Cytopia Limited

Cytopia aims to identify new candidate therapeutics (drug leads) for asthma and a range of inflammatory diseases. Many current drugs have significant side effects such as gastric upsets and ulcers and...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

More Information about "Cytopia Limited" on BioPortfolio

We have published hundreds of Cytopia Limited news stories on BioPortfolio along with dozens of Cytopia Limited Clinical Trials and PubMed Articles about Cytopia Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cytopia Limited Companies in our database. You can also find out about relevant Cytopia Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Asthma
Asthma is caused by inflammation of small tubes, called bronchi, which carry air in and out of the lungs. If you have asthma, the bronchi will be inflamed and more sensitive than normal.  When you come into contact with something that irritates your...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record